An analysis of these immune checkpoints in tumor and normal samples revealed significant differences in the expression of CD200, CD274, TIGIT, TNFRSF25, and TNFSF15 between the two groups (P < 0.05) (Figure 4E). Here, CD274 is linked to neoplasm.